Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
Just after midnight on the morning of Aug. 7, President Trump’s sweeping “reciprocal” tariffs took effect on dozens of international trading partners, marking another dramatic escalation of the administration’s “America First” trading policy.
In both of his administrations, President Trump promoted most-favored nation (MFN) pricing as a way to bring down drug costs in the United States. On July 31, 2025, President Trump sent letters to 17 pharmaceutical manufacturers demanding that they implement MFN prices or face the consequences.
Join us for One, Big Beautiful Webinar, a timely and essential session exploring the sweeping implications of H.R. 1 on the managed care landscape.
President Trump signed H.R.1, Republicans’ “big, beautiful” reconciliation bill, into law on July 4, 2025. Starting from that date, the law lays out effective dates and implementation dates for its numerous health provisions over the next few years, and beyond.
On June 28, AMCP Foundation turned 35 — and we’re kicking off a year-long celebration of impact, community, and forward momentum. From scholarships to research, you’ve helped shape the future of managed care pharmacy. Now, join us as we honor our past, celebrate the donors who make it all possible, and fuel the next 35 years.
#Drivefor35
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) August 2025 Issue
AMCP comments on Trump Administration demands for manufacturers to take action on Most-Favored-Nation pricing scheme
Ready to connect with other managed care professionals exploring AI, health disparities, and prior authorization? AMCP’s new LINK Interest Groups are your place to exchange ideas, stay ahead of trends, and tackle real-world challenges with peers and experts.
July 2025 Legislative Briefing
